Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
PMID: 19126664
MiR-1 functions as a crucial tumor inhibitor in ESCC (same as its role in HCC, GC, and ovarian cancer)
Investigators S-A, Canadian Critical Care Trials G, Australian, New Zealand Intensive Care Society Clinical Trials G, United Kingdom Critical Care Research G, Canadian Nephrology Trials N, et al
These injections are typically considered when other conservative treatments, such as medications, physical therapy, or lifestyle modifications have not provided sufficient relief
US$ 27.48
US$ 26.57
US$ 24.49
US$ 29.17
US$ 28.73
US$ 27.87
